High Doses of Statins Increases Life Expetancy for Older Patients
Dr. Nanette K. Wegner and colleauges from Emory University School of Medicine recently competed a study that suggested that high doses of atorvastatin (a statin) reduced coronary events more than low doses. The study involved over 10,000 patients over 65 who had coronary disease.
During the study, patients receiving higher doses of atorvastatin were heart 19 percent less likely to suffer a heart attack, stroke or cardiac arrest. Mortality rates were also lower for those taking the high doses of atrovastatin.
Links to Dr. Wegner’s paper and comments by other medical researchers are available at The Annals of Internal Medicine.